Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure (Q43759291)

26 November 2017

Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure (English)

1 reference

26 November 2017

1 reference

Kravcik S

1

1 reference

26 November 2017

Magill A

2

1 reference

26 November 2017

Sanghvi B

3

1 reference

26 November 2017

Ogden R

4

1 reference

26 November 2017

Cameron WD

5

1 reference

26 November 2017

Lewis R

6

1 reference

26 November 2017

Yu G

7

1 reference

26 November 2017

Badley AD

8

1 reference

26 November 2017

1 March 2001

1 reference

26 November 2017

1 reference

26 November 2017

2

1 reference

26 November 2017

2

1 reference

26 November 2017

160-170

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

26 November 2017

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

A simple relationship between viral load and survival time in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Active human immunodeficiency virus protease is required for viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

The HIV-1 protease as a therapeutic target for AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

Impaired infectivity of HIV-1 after a single point mutation in the POL gene to escape the effect of a protease inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF45L-FDKK-Y48N-N2BT

10.1310/F45L-FDKK-Y48N-N2BT

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference